Guild Investment Management’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-37,322
Closed -$5.05M 78
2021
Q4
$5.05M Sell
37,322
-1,915
-5% -$226K 5.11% 3
2021
Q3
$4.23M Buy
39,237
+5,566
+17% +$636K 4.07% 5
2021
Q2
$3.79M Sell
33,671
-1,800
-5% -$203K 3.67% 7
2021
Q1
$3.84M Buy
35,471
+1,571
+5% +$168K 4.11% 5
2020
Q4
$3.63M Sell
33,900
-500
-1% -$48K 4% 5
2020
Q3
$3.01M Buy
34,400
+2,050
+6% +$193K 4.15% 5
2020
Q2
$3.18M Buy
32,350
+4,080
+14% +$359K 4.51% 5
2020
Q1
$2.15M Buy
+28,270
New +$2.41M 4.68% 6

Other funds holding ABBV

Guild Investment Management's ABBV Position: Q1 2022 in Review

Guild Investment Management sold out of AbbVie (ABBV) in Q1 2022, closing a stake of 37,322 shares — an estimated $5.05M sold.

Guild Investment Management first reported a position in ABBV in Q1 2020 and held it in 8 quarters. The position peaked at $5.05M in Q4 2021. 3,052 funds tracked by Wall St. Rank hold ABBV as of Q1 2022.

  • Guild Investment Management reported no remaining AbbVie position as of Q1 2022 after selling out during the quarter.
  • Guild Investment Management sold 37,322 AbbVie shares in Q1 2022, an estimated $5.05M.
  • Guild Investment Management first reported a position in AbbVie in Q1 2020 and held it in 8 quarters.
  • Guild Investment Management's AbbVie position peaked at $5.05M in Q4 2021.
  • 3,052 funds tracked by Wall St. Rank held AbbVie as of Q1 2022.

Based on Guild Investment Management's 13F filing for Q1 2022, filed 10 May 2022.